+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Double blind clinical trial investigating the efficacy and long term tolerance of torasemide 200 mg po compared with furosemide 500 mg po and placebo po in patients with chronic renal failure on hemodialysis a multicenter study



Double blind clinical trial investigating the efficacy and long term tolerance of torasemide 200 mg po compared with furosemide 500 mg po and placebo po in patients with chronic renal failure on hemodialysis a multicenter study



Proceedings of the 2nd International Symposium on Torasemide, Munich, October 21 - 23, 1988: 249-258




(PDF emailed within 1 workday: $29.90)

Accession: 031006311

Download citation: RISBibTeXText


Related references

Controlled double blind clinical trial on the efficacy and tolerance of torasemide in comparison with furosemide in patients with congestive heart failure a multicenter study. Krueck, F , E Mutschler And H Knauf (Ed ) Progress in Pharmacology And Clinical Pharmacology, Vol 8 No 1 Torasemide: Clinical Pharmacology And Therapeutic Applications; 2nd International Symposium on Torasemide, Munich, Germany, October 21-23, 1988 Ix+273p Gustav Fischer Verlag: Stuttgart, Germany; Vch Publishers Inc : Deerfield Beach, Florida, Usa Illus Paper 121-126, 1990

Major depression complicating hemodialysis in patients with chronic renal failure: A multicenter, double-blind, controlled clinical trial of S-adenosyl-L-methionine versus placebo. Current Therapeutic Research 54(6): 680-686, 1993

Comparative placebo-controlled clinical trial on the acute diuretic and natriuretic effect of torasemide versus furosemide in patients with chronic renal failure. Puschett, J B International Congress Series; Diuretics IV: Chemistry, pharmacology and clinical applications: 131-134, 1993

Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study. Cardiovascular Drugs and Therapy 27(6): 573-579, 2014

A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction. Journal of Cardiac Failure 17(12): 973-981, 2012

Long-term efficacy of lamivudine in the treatment of patients with chronic hepatitis B virus infection-A multicenter randomised, double-blind, placebo controlled trial. Gastroenterology 116(4 PART 2): A848, 1999

Multicenter, double-blind, placebo-controlled study of long-term endothelin blockade with bosentan in chronic heart failure Results of the REACH-1 trial. Circulation 98(17 SUPPL ): I3, Oct 27, 1998

Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide. Archives Internationales de Pharmacodynamie et de Therapie 260(1): 151-158, 1982

Randomized multicenter double blind placebo controlled study of the efficacy of flosequinan a new long acting vasodilator drug in patients with chronic heart failure. Circulation 82(4 SUPPL 3): III323, 1990

Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure. Arzneimittel-Forschung 38(1a): 212-214, 1988

Torasemide versus furosemide in cirrhosis: A long-term, double-blind, randomized clinical study. Clinical Investigator 71(7): 579-584, 1993

A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failure. Journal of Ethnopharmacology 186: 136-142, 2017

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 92(6): 1499-1506, 1995

No-reflow protection and long-term efficacy for acute myocardial infarction with Tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT Trial). Chinese Medical Journal 123(20): 2858-2864, 2011

Beneficial long-term hemodynamic and clinical effects of amlodipine in chronic heart failure Results of a multicenter randomized, double-blind, placebo-controlled, dose-ranging study. Circulation 90(4 PART 2): I603, 1994